Alzheimer's disease (AD) currently presents one of the biggest healthcare issues in the developed countries. There is no effective treatment capable of slowing down disease progression. In recent years the main focus of research on novel pharmacotherapies was based on the amyloidogenic hypothes...
Bibliographische Detailangaben
| Veröffentlicht in: | Neural plasticity. - 1998. - 2016(2016) vom: 15., Seite 8501693
|
|---|
| 1. Verfasser: |
Folch, Jaume
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Petrov, Dmitry,
Ettcheto, Miren,
Abad, Sonia,
Sánchez-López, Elena,
García, M Luisa,
Olloquequi, Jordi,
Beas-Zarate, Carlos,
Auladell, Carme,
Camins, Antoni |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | English |
|---|
| Veröffentlicht: |
2016
|
|---|
| Zugriff auf das übergeordnete Werk: | Neural plasticity
|
|---|
| Schlagworte: | Journal Article
Research Support, Non-U.S. Gov't
Review
Amyloid beta-Peptides
Benzamides
Benzodioxoles
GRM5 protein, human
Piperidines
PrPC Proteins
Protein Kinase Inhibitors
mehr...
Pyridines
Quinazolines
Receptor, Metabotropic Glutamate 5
Receptors, N-Methyl-D-Aspartate
Receptors, Serotonin
Thiazoles
serotonin 6 receptor
saracatinib
9KD24QGH76
FYN protein, human
EC 2.7.10.2
Proto-Oncogene Proteins c-fyn
masitinib
M59NC4E26P |
|---|